Chargement de la fiche…
Chargement de la fiche…

Praticien hospitalier
Photo : Christophe Meneboeuf, CC BY-SA 3.0, Wikimedia Commons
Vous êtes Dr Philippe Dieude ? Présentation, expertises, actes, site du cabinet : faites de cette fiche la page de votre cabinet.
Configurer votre fiche gratuitement →Dr Philippe Dieude est rhumatologue à Paris 18e (75877). Il consulte à GHU APHP NUP SITE BICHAT C BERNARD, 46 Rue HENRI HUCHARD, 75877 Paris 18e Arrondissement.
Consulter
GHU APHP NUP SITE BICHAT C BERNARD
46 Rue HENRI HUCHARD, 75877 Paris 18e Arrondissement
Hospitalier
Dr Philippe Dieude, c'est vous ?
Faites de cette fiche la page de votre cabinet.
Pour aller plus loin
Remboursement
Pratique
Thèmes de publication
Domaines déduits des publications référencées sur PubMed.
Faits issus de registres publics et des déclarations du praticien — aucun classement.
DES Rhumatologie · Rhumatologie (SM) — Diplôme d'études spécialisées
DE Docteur en médecine — Capacité / certificat d'études spéciales
2008–2026
Inserm
2024
Centre National de la Recherche Scientifique
2019
Université de Bretagne Occidentale
2016
Centre National de la Recherche Scientifique
2015
Universidad de Cantabria
2012
Universidade de São Paulo
travaux indexés
citations
h-index
i10
Indicateurs calculés par OpenAlex (base bibliographique ouverte) · ORCID 0000-0002-4814-0307.
Les plus citées
2026Annals of the rheumatic diseases85 citations
ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease developed by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR) Endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG)
En bref
Dr Philippe Dieude consulte à GHU APHP NUP SITE BICHAT C BERNARD, 46 Rue HENRI HUCHARD, 75877 Paris 18e Arrondissement. Adresses issues de l'Annuaire Santé (ANS).
Par téléphone au 01 40 25 80 80 (numéro publié à l'Annuaire Santé). Un lien de recherche Doctolib est proposé sur cette page : si le praticien y est inscrit, son profil figure normalement parmi les résultats.
Identité, diplômes et lieux d'exercice : Annuaire Santé (ANS, licence ouverte). Conventionnement et carte Vitale : Assurance Maladie. Publications : bases scientifiques publiques (PubMed, HAL, OpenAlex), affichées seulement si le nom du praticien figure parmi les auteurs. Le praticien peut corriger sa fiche ou en demander le retrait à tout moment ; en cas d'homonymie, signalez-le.
Autour du cabinet
Vous pouvez aussi demander le retrait de la fiche.
Aperçu de votre présentation
Rhumatologue à Paris 18e, j'accompagne…
Exemple : vous choisissez vos propres domaines.
2024The Lancet. Rheumatology80 citations
Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts
2026The Lancet. RheumatologyPubMed
Innovative therapies in rheumatoid arthritis: CAR T cells and bispecific antibodies
2026Nature reviews. RheumatologyPubMed
Lung disease in rheumatoid arthritis
2026The Lancet. Respiratory medicinePubMed
Rheumatoid arthritis-associated interstitial lung disease: screening, diagnosis, and treatment-an expert group consensus statement
2026Respiratory medicine and researchPubMed
Rheumatoid arthritis-associated interstitial lung disease: A review
2026Archivos de bronconeumologiaPubMed
Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD): An Official 2025 ALAT Clinical Practice Guideline
2026Respirology (Carlton, Vic.)PubMed
Effects of Air Pollution Exposure and the MUC5B rs35705950 Variant on Interstitial Lung Disease Risk in Patients With Rheumatoid Arthritis
2026Joint bone spinePubMed
Baseline characteristics of the TRANSLATE2 cohort: A prospective study on rheumatoid arthritis-associated interstitial lung disease
2025The European respiratory journalPubMed
Short telomere length is associated with accelerated lung disease progression in rheumatoid arthritis-associated interstitial lung disease
2025Rheumatology (Oxford, England)PubMed
Value of lung ultrasonography for screening interstitial lung disease in patients with rheumatoid arthritis
2025Seminars in arthritis and rheumatismPubMed
Incidence rates of interstitial lung disease events among patients with rheumatoid arthritis treated with abatacept or placebo, with background methotrexate: a post hoc pooled analysis from a compendium of clinical trials
2025RMD openPubMed
Evaluation of rheumatoid arthritis-associated interstitial lung disease in patients treated with JAK inhibitors: a MAJIK-SFR cohort study
2025Annals of the rheumatic diseasesPubMed
Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo- controlled, double-blind trial
2024Joint bone spinePubMed
2024 update of the recommendations of the French Society of Rheumatology for the diagnosis and management of patients with rheumatoid arthritis
2024ACR open rheumatologyPubMed
Clinical Course of Interstitial Lung Disease in Patients With Rheumatoid Arthritis
2024Clinical rheumatologyPubMed
Forced vital capacity trajectories and risk of lung transplant and ILD-related mortality among patients with rheumatoid arthritis-associated interstitial lung disease
2024Rheumatology advances in practicePubMed
RPA3-UMAD1 rs12702634 and rheumatoid arthritis-associated interstitial lung disease in European ancestry
2024BMC rheumatologyPubMed
Design of ANCHOR-RA: a multi-national cross-sectional study on screening for interstitial lung disease in patients with rheumatoid arthritis
2024ThoraxPubMed
Rheumatoid arthritis and idiopathic pulmonary fibrosis: a bidirectional Mendelian randomisation study
2024Arthritis & rheumatology (Hoboken, N.J.)PubMed
Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission
2024Annals of the rheumatic diseasesPubMed
Counteracting tryptophan metabolism alterations as a new therapeutic strategy for rheumatoid arthritis
2024Seminars in arthritis and rheumatismPubMed
Effectiveness and tolerability of antifibrotics in rheumatoid arthritis-associated interstitial lung disease
2024ThoraxPubMed
Short peripheral blood leukocyte telomere length in rheumatoid arthritis-interstitial lung disease
2026Rheumatology (Oxford, England)PubMed
Characteristics of patients with isolated anti-Ku antibodies
2026Journal of clinical densitometry : the official journal of the International Society for Clinical DensitometryPubMed
Opportunistic MRI assessment of low bone mineral density in patients with inflammatory bowel disease
2026RMD openPubMed
Characteristics and outcomes of anti-Ku antibody-associated interstitial lung disease: a retrospective study of 60 patients
2026American journal of respiratory and critical care medicinePubMed
Idiopathic pulmonary fibrosis risk loci in East Asian populations mirror those of European populations
2026Annals of the rheumatic diseasesPubMed
A genetic variant of BAFF is associated with the risk of lymphoma in Sjögren disease
2025Arthritis & rheumatology (Hoboken, N.J.)PubMed
Distinct Pathophysiologic Pathways Support Stratification of Sjögren's Disease Based on Symptoms, Clinical, and Routine Biological Data
2025RMD openPubMed
Impact of Sjögren's disease on quality of sexual life using the Qualisex score
2024The Lancet. RheumatologyPubMed
Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts
2025Seminars in arthritis and rheumatismPubMed
Incidence rates of interstitial lung disease events among patients with rheumatoid arthritis treated with abatacept or placebo, with background methotrexate: a post hoc pooled analysis from a compendium of clinical trials
2024Rheumatology (Oxford, England)PubMed
Efficacy and management of tocilizumab in polymyalgia rheumatica: results of a multicentre retrospective observational study
2024Arthritis & rheumatology (Hoboken, N.J.)PubMed
Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission
2025Seminars in arthritis and rheumatismPubMed
Incidence rates of interstitial lung disease events among patients with rheumatoid arthritis treated with abatacept or placebo, with background methotrexate: a post hoc pooled analysis from a compendium of clinical trials
2024Revue des maladies respiratoiresPubMed
[Low-dose methotrexate: Indications and side effects, particularly in cases of diffuse interstitial pneumonia]
2026European journal of nuclear medicine and molecular imagingPubMed
Diagnostic accuracy of (18)F-FDG PET-CT scores in distinguishing polymyalgia rheumatica from other inflammatory rheumatic diseases: a multicentre retrospective study (RHUMATEP)
2024Rheumatology (Oxford, England)PubMed
Efficacy and management of tocilizumab in polymyalgia rheumatica: results of a multicentre retrospective observational study
2026The European respiratory journalPubMed
ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease
2026Annals of the rheumatic diseasesPubMed
ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease developed by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR) Endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG)
2026 · Article
FADD Protein for the Early Diagnosis of Rheumatoid Arthritis
2026 · Article
FloREN: Decoding Immune Regulatory Networks through Interpretable Graph Transformer Patient Representations
2026 · Article
Factors associated with anakinra effectiveness and risk of infection in crystal-related flares
2026 · Article
A genetic variant of BAFF is associated with the risk of lymphoma in Sjögren disease
2025 · Article
Baseline characteristics of the TRANSLATE2 cohort: a prospective study on rheumatoid arthritis-associated interstitial lung disease
2025 · Article
Cluster analysis identifies three clinical patterns of patients with systemic autoimmune diseases and anti-Ku antibodies
2025 · Article
Comment on: Hydroxychloroquine levels in pregnancy and materno–fetal outcomes in Systemic Lupus Erythematosus patients: Reply
2025 · Article
Erratum à « Actualisation 2024 des recommandations de la Société française de rhumatologie pour le diagnostic et la prise en charge des personnes souffrant de polyarthrite rhumatoïde » [Rev. Rhum. 2024;91 (6):663–93]
Publications affichées uniquement lorsque le nom du praticien figure parmi les auteurs. Une erreur d'homonymie ? Signalez-la depuis le lien en bas de page.
2026Rheumatology advances in practicePubMed
900 patients evaluated within a median of 1 day from referral in a very early arthritis clinic in France
2024RMD openPubMed
Characterisation of airway disease associated with Sjögren disease